Parkinsons Disease
Parkinson’s disease is a progressive neurodegenerative disorder characterized by motor symptoms such as tremor, rigidity, and bradykinesia, as well as non-motor symptoms affecting mood, sleep, and cognition. It results from the loss of dopaminergic neurons in the substantia nigra and dysfunction in basal ganglia circuits.
The Parkinson’s Disease session explores current understanding of pathophysiology, diagnosis, and treatment innovations. Researchers discuss molecular and genetic factors influencing disease onset and progression.
At the Parkinson’s Disease Conference, neurologists, neuroscientists, and clinicians present developments in early biomarkers, deep brain stimulation (DBS), gene therapy, and neuroprotective drugs. The session highlights the integration of rehabilitation, digital health, and AI-driven monitoring.
This session is designed for professionals involved in movement disorders, neurogenetics, and therapeutic neurology. Participants will learn the latest approaches for improving motor control, delaying disease progression, and enhancing patient quality of life.
Recent studies in Neurogenetics and Genomics have identified novel genetic mutations and pathways involved in dopamine metabolism, offering promising drug targets for personalized therapy.
Ready to Share Your Research?
Submit Your Abstract Here →Key Scientific and Clinical Focus Areas
Therapeutic Innovations
- Deep brain stimulation and focused ultrasound interventions
- Gene therapy and neurotrophic factor delivery systems
Rehabilitation and Supportive Care
- Physiotherapy, speech, and occupational therapy strategies
- Mind–body practices improving motor coordination and balance
AI and Precision Medicine
- Predictive analytics for disease progression tracking
- Personalized pharmacological regimens guided by genetic data
Molecular and Cellular Mechanisms
- α-synuclein aggregation and mitochondrial dysfunction
- Dopaminergic neuron degeneration pathways
Diagnostics and Biomarkers
- Neuroimaging and cerebrospinal fluid analysis for early detection
- Wearable devices monitoring motor performance and tremor
Why Attend
Understand the Latest Advances in Parkinson’s Science
Gain insight into genetic and molecular discoveries shaping therapy.
Explore Cutting-Edge Therapeutic Tools
Learn how DBS, gene therapy, and AI revolutionize Parkinson’s treatment.
Collaborate with Movement Disorder Experts
Engage with global neurologists developing advanced management protocols.
Transform Care Through Innovation
Integrate evidence-based therapies enhancing patient quality of life.
Related Sessions You May Like
Join the Global Neurology & Neuroscience Community
Connect with leading neurologists, neuroscientists, and healthcare professionals from across the globe. Share your groundbreaking research and gain insights into the latest advancements in brain science, neurological disorders, and innovative therapies shaping the future of neuroscience.
